These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 9613679

  • 1. Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection.
    Di Carlo E, Coletti A, Modesti A, Giovarelli M, Forni G, Musiani P.
    Eur Cytokine Netw; 1998 Mar; 9(1):61-8. PubMed ID: 9613679
    [Abstract] [Full Text] [Related]

  • 2. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
    Musiani P, Allione A, Modica A, Lollini PL, Giovarelli M, Cavallo F, Belardelli F, Forni G, Modesti A.
    Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
    [Abstract] [Full Text] [Related]

  • 3. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.
    Giovarelli M, Musiani P, Modesti A, Dellabona P, Casorati G, Allione A, Consalvo M, Cavallo F, di Pierro F, De Giovanni C.
    J Immunol; 1995 Sep 15; 155(6):3112-23. PubMed ID: 7673726
    [Abstract] [Full Text] [Related]

  • 4. Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumour.
    Di Carlo E, Modesti A, Coletti A, Colombo MP, Giovarelli M, Forni G, Diodoro MG, Musiani P.
    J Pathol; 1998 Dec 15; 186(4):390-7. PubMed ID: 10209488
    [Abstract] [Full Text] [Related]

  • 5. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.
    Allione A, Consalvo M, Nanni P, Lollini PL, Cavallo F, Giovarelli M, Forni M, Gulino A, Colombo MP, Dellabona P.
    Cancer Res; 1994 Dec 01; 54(23):6022-6. PubMed ID: 7954438
    [Abstract] [Full Text] [Related]

  • 6. IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
    Comes A, Di Carlo E, Musiani P, Rosso O, Meazza R, Chiodoni C, Colombo MP, Ferrini S.
    Eur J Immunol; 2002 Jul 01; 32(7):1914-23. PubMed ID: 12115611
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S, Xie K, Bucana CD, Ullrich SE, Bar-Eli M.
    Clin Cancer Res; 1996 Dec 01; 2(12):1969-79. PubMed ID: 9816156
    [Abstract] [Full Text] [Related]

  • 8. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
    Giovarelli M, Musiani P, Garotta G, Ebner R, Di Carlo E, Kim Y, Cappello P, Rigamonti L, Bernabei P, Novelli F, Modesti A, Coletti A, Ferrie AK, Lollini PL, Ruben S, Salcedo T, Forni G.
    J Immunol; 1999 Nov 01; 163(9):4886-93. PubMed ID: 10528190
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S, Reichert TE, Kashii Y, Suminami Y, Chikamatsu K, Whiteside TL.
    Cancer Gene Ther; 1997 Nov 01; 4(6):366-76. PubMed ID: 9408607
    [Abstract] [Full Text] [Related]

  • 11. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor.
    Fioretti F, Fradelizi D, Stoppacciaro A, Ramponi S, Ruco L, Minty A, Sozzani S, Garlanda C, Vecchi A, Mantovani A.
    J Immunol; 1998 Jul 01; 161(1):342-6. PubMed ID: 9647242
    [Abstract] [Full Text] [Related]

  • 12. Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential.
    Di Carlo E, Modesti A, Castrilli G, Landuzzi L, Allione A, de Giovanni C, Musso T, Musiani P.
    J Pathol; 1997 May 01; 182(1):76-85. PubMed ID: 9227345
    [Abstract] [Full Text] [Related]

  • 13. Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes.
    Musiani P, Modesti A, Brunetti M, Modica A, Vitullo P, Gulino A, Bosco MC, Colombo MP, Nanni P, Cavallo F.
    Nat Immun; 1994 May 01; 13(2-3):93-101. PubMed ID: 8173240
    [Abstract] [Full Text] [Related]

  • 14. Prevention of adenocarcinoma colon 26-induced cachexia by interleukin 10 gene transfer.
    Fujiki F, Mukaida N, Hirose K, Ishida H, Harada A, Ohno S, Bluethmann H, Kawakami M, Akiyama M, Sone S, Matsushima K.
    Cancer Res; 1997 Jan 01; 57(1):94-9. PubMed ID: 8988047
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice.
    Di Carlo E, Meazza R, Basso S, Rosso O, Comes A, Gaggero A, Musiani P, Santi L, Ferrini S.
    J Pathol; 2000 Jun 01; 191(2):193-201. PubMed ID: 10861581
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
    Ledda MF, Adris S, Bravo AI, Bover L, Carbone C, Paleolog E, Mordoh J, Chernajovsky Y, Podhajcer OL.
    Cell Mol Biol (Noisy-le-grand); 1996 Jul 01; 42(5):769-78. PubMed ID: 8832108
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.